CLINICAL AND PREVENTIVE EFFICACY OF INTERFERON INDUCTOR IN VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN YOUNGER PRESCHOOL AGE
https://doi.org/10.15690/pf.v9i1.169
Abstract
About the Authors
F. S. KharlamovaRussian Federation
V. F. Utchaykin
Russian Federation
O. V. Kladova
Russian Federation
E. M. Sergeeva
Russian Federation
V. G. Nesterenko
Russian Federation
References
1. Dondurei E.A., Osidak L.V., Gonchar V.V. and others. Pandemic and seasonal AH1N1 influenza in hospitalized children. Children infections. 2011, 10 (2): 14-21.
2. Garsia-Sastre A., Egorov A., Matassov D. and others Influenza A virus lacking the NSI gene replicates in interferon-deficient systems. Virology. 1998, 252 (2): 324-330.
3. Ramaswamy M., Shi Lei, Monick M.M.et al. Specific inhibition of type 1 interferon signal transduction by respiratory syncytial virus. AmJRespCellMolBiol. 2004, 30: 893-900.
4. Ershov F.I., Kiselev O.I. Interferon and their inducers (from molecules to medicine). M. GEOTAR Media. 2005. P.368
5. Namazova L.S., et al. Often sick children of megacities: treatment and prevention of acute respiratory infections. Pediatric Pharmacology.2006; 1.
6. E.V. Obraztsova, Osidak L.V., Golovacheva E.G. Interferon preparations and inducers for influenza and ARI in children .Children infection. 2010, 9 (1): 35-40
7. Ershov F.I. Inducers of interferon are a new generation of immune modulators. TerraMedica. 1998; 2: 2-7.
8. Deryabin P.G. Inactivating effect of the drug Kagocel on infectious properties of the highly pathogenic avian influenza A (H5N1). Report of the Governmental Management Scientific Research Institute of Virology named after D.I. Ivanovskiy RAMS. Moscow, 2006.
9. Kiselev O.I. Study of virus inhibiting activity of Kagocel in combination with arbidol against pandemic viral isolates against influenza A (H1N1) . Report SRR SRI of flu Health Care RAMS S-Petersburg 2009.
10. Kharlamova F.S., Uchaikin V.F., S.L. Bevza et al. Clinical efficacy of Kagocel with SARS for steno sing laryngeal tracheid in children .Children infections.2008 4: 28-35.
11. Kharlamova F.S., Kladova O.V., Sergeeva E.M. et a.l Clinical efficacy of Kagocel in flu and ARI in children from 3 to 6 years old. Children infection. 2010, 9 (4): 34-41.
12. Temporary guidelines of the Health Ministry of Russian Federation "Schedule of treatment and prevention of influenza caused by highly pathogenic type A/H1N1 for adults» № 24-0/10/1-4053 ot.30.06.2009.
13. F.I. Ershov, Saytkulov A.M, Tazulahova E.B., H.A. Aslamov. Plant material - active inducers of interferon in cell culture. Sat: Interferon-89. Moscow. 1989: 37-42.
14. Sazonov N.V. Report of study the general toxic action Kagocel in immature rats. Moscow, 2002.
15. Kladova O.V. Immune pathogenesis, clinical picture and treatment of recurrent croup in children. Thesis of Doctor of Medical Science. Moscow, 2003. P.55.
Review
For citations:
Kharlamova F.S., Utchaykin V.F., Kladova O.V., Sergeeva E.M., Nesterenko V.G. CLINICAL AND PREVENTIVE EFFICACY OF INTERFERON INDUCTOR IN VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN YOUNGER PRESCHOOL AGE. Pediatric pharmacology. 2012;9(1):81-89. https://doi.org/10.15690/pf.v9i1.169